This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs) for therapeutic agents. It serves as a chiral building block in the creation of drugs targeting neurological and psychiatric disorders, such as antidepressants and anxiolytics. Its structural features, including the fluorine and methoxy groups, enhance binding affinity and selectivity toward specific biological targets, making it valuable in drug design. Additionally, it is employed in the study of receptor-ligand interactions, aiding in the understanding of molecular mechanisms underlying various diseases. Its hydrochloride form ensures stability and solubility, facilitating its use in experimental and formulation processes.